-7.3%
CTSH vs RCAT
+762.9%
-770.2%
-56.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | RCAT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | -2.0% | -1.6% | -3.6% |
| 7D | -2.7% | -1.4% | -1.3% | -2.7% |
| 30D | +12.4% | -3.3% | +15.7% | +12.4% |
| 3M | +17.4% | -43.2% | +60.6% | +18.9% |
| 6M | -3.1% | -43.2% | +40.1% | -2.2% |
| YTD | -23.6% | +5.5% | -29.1% | -24.8% |
| 1Y | -10.8% | -1.6% | -9.2% | -12.6% |
| All | -7.3% | +762.9% | -770.2% | -15.1% |
Cumulative growth
Daily Returns
Daily percentage return beside RCAT.
Daily Out/Under-Performance
Portfolio return minus RCAT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RCAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded RCAT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling